Buying Kisspeptin-10: A Decapeptide Fragment and What to Check

Kisspeptin-10 is listed at 10 mg for $81.20. The name carries a number, and unlike most catalogue numbers it is not a strength — it is a length, and getting it wrong means buying a different molecule.

This covers what the fragment is, why catalogues list it rather than the parent peptide, what its one terminal modification does to analysis, and what to read before ordering. Everything about biological activity is reported from published work and named by model. The material is supplied for laboratory research only.

A fragment, named by its length

The KISS1 gene encodes a precursor protein that is processed into several peptides of different lengths, all sharing the same C-terminal region. The family is named by residue count: kisspeptin-54, kisspeptin-14, kisspeptin-13 and kisspeptin-10. The number is how many residues the fragment has, counted from the C-terminal end of the shared region.

Kisspeptin-10 is the shortest of these and is the form catalogues generally list. Two practical reasons. The shorter the sequence, the cheaper and cleaner the synthesis — a 10-residue chain is a routine solid-phase preparation where a 54-residue chain is a substantially harder and more expensive one. And published work established early that the C-terminal region is where the receptor interaction resides, so the short fragment is the one most laboratory work uses.

The consequence for a buyer is that 'kisspeptin' without a number is an incomplete product name. Reading peptide nomenclature covers fragments, numbering conventions and how modifications are written, which is the vocabulary needed to confirm a certificate describes the right molecule.

The amidated terminus

Kisspeptin-10 carries a C-terminal amide rather than a free carboxylic acid. In the natural processing of the precursor that amidation is enzymatic, and in synthesis it is achieved by choosing the resin the chain is built on.

It matters on two counts. The amide is required for the molecule to behave as the natural fragment does in the systems published work describes, so a free-acid version is a different compound with different behaviour. And the modification shifts the molecular mass by approximately one dalton — a small difference, but one that mass spectrometry resolves easily and that a certificate should therefore confirm.

Ask for the sequence written with the terminal modification shown explicitly. A certificate that names the product and gives a purity figure without stating the sequence and the terminus is documenting a label rather than a molecule. Mass spectrometry and peptide identity covers what the measurement proves and where it stops.

Solubility is the handling problem

Kisspeptin-10's sequence includes several hydrophobic residues, and in practice it is among the less cooperative short peptides to get into solution. A buyer planning a reconstitution volume from a general rule rather than from the compound's own documentation is the usual source of difficulty.

Why some peptides resist dissolving covers the chemistry and the standard approaches. Reconstitution arithmetic covers the volume and concentration calculation, and reconstitution solvents compared covers the choice of diluent, which for a difficult sequence is not an afterthought.

The practical point at purchase is to confirm the supplier states a recommended reconstitution approach for this compound specifically rather than offering a generic instruction sheet covering a whole catalogue.

What the catalogue name does not settle

Three things remain open after a product name and a strength, and all three belong in the purchase conversation rather than in a discovery after delivery.

Species origin. The kisspeptin sequences of different species are not identical, and published work uses more than one. A certificate that gives the sequence settles this; a product name does not. Where work is being compared against a particular paper, the sequence in that paper is the specification to match.

Salt form. The counter-ion travels into the vial and onto the scale, so two vials with the same labelled mass and the same purity can hold different quantities of peptide. TFA and acetate salt forms covers the arithmetic, and the practical rule is to compare like with like or to compare net peptide content directly.

Whether the material has been characterised for this sequence or adapted from a related one. Suppliers producing several members of a peptide family sometimes run a single analytical method across all of them. That is reasonable practice when the method genuinely separates them and poor practice when it does not, and asking which applies is a fair question.

Storage and the dry state

The sealed vial should be kept cold, dry and dark, and the dry state is where almost all of the material's stability lives. Lyophilisation explained covers why research peptides ship as powder and what the freeze-dried cake is doing.

Residual moisture is the quiet variable. A cake that was not dried thoroughly carries water that drives hydrolysis slowly over months, and it is the test most certificates omit entirely. Residual moisture in lyophilised peptides covers what the measurement is and why its absence from a certificate is worth noticing.

Once reconstituted the material is on a much shorter clock, and for a sequence that is already difficult to dissolve there is an additional temptation to keep a prepared solution rather than repeat the work. That is the wrong economy. Aliquot at the point of first reconstitution and accept the effort once, rather than cycling a single container repeatedly — freeze-thaw cycles and aliquoting covers why each cycle costs something.

Where it sits beside the other reproductive-axis listings

Kisspeptin-10 is catalogued near Gonadorelin at 10 mg for $112.00, and the two are often considered together. They are chemically distinct and the comparison is worth making explicitly.

Both are decapeptides and both are amidated, which makes the price difference a question worth asking about rather than assuming. Synthesis difficulty, scale and purification route all contribute. Gonadorelin, kisspeptin, oxytocin and HCG covers how differently these four molecules are constructed despite sharing a catalogue section, and buying gonadorelin covers the other listing in detail.

A note on the family

Because the KISS1 precursor yields several fragments, a catalogue may list more than one of them, and the longer forms are substantially more expensive to synthesise. If a supplier offers kisspeptin-54 alongside kisspeptin-10 at similar prices, that is a question rather than a bargain.

The reverse situation is more common: a listing that simply says kisspeptin, with a price consistent with the 10-residue fragment. In that case the price is telling you which molecule it probably is, and the certificate should confirm it. Price as a cross-check on identity is a crude instrument, but for peptide families where length drives cost steeply it is a useful one.

What to check before ordering

The sequence and its length, written out, so that 'kisspeptin-10' is confirmed rather than assumed. The C-terminal amide, shown explicitly. Purity by a named chromatographic method with stated gradient conditions — HPLC purity explained covers what the figure measures and what it does not. Related substances rather than a single purity number. And net peptide content, without which the price cannot be compared to anything.

Reading a certificate of analysis line by line covers the whole document, and what a certificate of analysis does not test for covers the gaps that remain even in a good one.

Handling

Cold, dry and dark for the sealed vial. Once reconstituted, aliquot into single-session volumes rather than returning the same container to the freezer repeatedly — freeze-thaw cycles and aliquoting covers why. How peptides degrade covers the routes that matter, which for a sequence of this composition are principally hydrolysis and aggregation rather than oxidation.